Stocks are up Friday, with the Dow Jones Industrial Average up 1.06%, the Nasdaq up 0.74% and the S&P 500 up 0.82%. Friday's winners include a company beating second-quarter earnings and a biotech firm soon to announce results for a clincal trial. The loser had its price target cut by a prominent analyst.
These are Friday's market winners and loser.
Shares of Splunk, Inc. (NASDAQ: SPLK) are up 17.93% to $35.97 on trading volume of 1.9 million shares. While the data-mining software company reported a second-quarter loss of 1 cent a share, it was better than Wall Street expectations of a 4-cent-a-share loss. The 52-week high is $37.57.
Shares of StemCells Inc. (NASDAQ: STEM) are up 12.24% to $2.20 on trading volume of 5 million shares. The biotechnology company's stock is rallying before it announces results of a clinical durg trial to treat chronic spinal cord injury. The 52-week high is $2.55.
Shares of Facebook Inc. (NASDAQ: FB) are down 3.92% to $18.34 on trading volume of 25.5 million shares. BMO Capital has cut its price target to $15. Before Friday, the 52-week low was $18.75.
Follow him on Twitter: SWeigley
Filed under: 24/7 Wall St. Wire Tagged: FB, SPLK, STEM